Drug Pipeline

Multi-peptide CMV-Modified Vaccinia Ankara Vaccine Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
5
Recruiting
1
Top Sponsors
Active Studies by Phase
Phase 2
2
Phase 1
3
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06059391 CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of… Acute Lymphoblastic Leukemia Recruiting
NCT02506933 Multi-antigen CMV-MVA Triplex Vaccine in Reducing CMV Complications in Patients… Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Active, Not Recruiting
Phase 1
NCT05432635 Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA… B-Cell Non-Hodgkin Lymphoma Recruiting
NCT05801913 Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA… High Grade B-Cell Non-Hodgkin's Lymphoma Recruiting
NCT07020533 A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the… Accelerated Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive Recruiting
Early Phase 1
NCT06735690 Allogeneic CMV-Specific CD19-CAR T Cells Plus CMV-MVA Triplex Vaccine After Matched… Acute Lymphoblastic Leukemia Recruiting
Sponsors Running Multi-peptide CMV-Modified Vaccinia Ankara Vaccine Trials
City of Hope Medical Center (6)
Disease Areas
Non-Hodgkin Lymphoma (5) Leukemia (4) Acute Lymphoblastic Leukemia (ALL) (4) Acute Myeloid Leukemia (AML) (3) Chronic Lymphocytic Leukemia (CLL) (3) Hodgkin Lymphoma (3) Myelodysplastic Syndromes (MDS) (3) Myelofibrosis (3) Chronic Myeloid Leukemia (CML) (2) DLBCL (1)
Get alerts when Multi-peptide CMV-Modified Vaccinia Ankara Vaccine trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free